The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage

Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

NCT02792335 ·Status: COMPLETED

Replication Of An Early Evaluation Of 30-Day Readmissions Among Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran, Rivaroxaban, Apixaban, or Warfarin In The U.S

NCT02769078 ·Status: COMPLETED

Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty

NCT04878497 ·Status: UNKNOWN

Direct Oral Anticoagulants and Venous Thromboembolism

NCT02833987 ·Status: COMPLETED

Comparative Effectiveness of Oral Anticoagulants

NCT01847547 ·Status: COMPLETED

Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism

NCT00291330 ·Status: COMPLETED ·Phase: PHASE3

A Study Based on Japanese Medical Records That Looks at Bleeding Events in People With Atrial Fibrillation and Coronary Artery Disease Who Start Taking Either Dabigatran, Rivaroxaban, or Warfarin

NCT05051904 ·Status: COMPLETED

High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France

NCT05038228 ·Status: ACTIVE_NOT_RECRUITING

Dabigatran Versus Warfarin With NVAF Who Undergo PCI

NCT03536611 ·Status: UNKNOWN ·Phase: PHASE4

DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation

NCT00806624 ·Status: COMPLETED ·Phase: PHASE2

The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients

NCT02646267 ·Status: UNKNOWN ·Phase: PHASE4

Management of Major Bleeding Events in Atrial Fibrillation Patients Using Pradaxa

NCT02149303 ·Status: COMPLETED

Monitor System for the Safety of Dabigatran Treatment

NCT02414035 ·Status: COMPLETED

Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism

NCT01976507 ·Status: COMPLETED ·Phase: PHASE4

An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation

NCT00403767 ·Status: COMPLETED ·Phase: PHASE3

Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)

NCT00680186 ·Status: COMPLETED ·Phase: PHASE3

The DARE Warfarin CER Study

NCT03271450 ·Status: UNKNOWN

Comparative Study of Oral Anticoagulation in Left Ventricular Thrombi

NCT03926780 ·Status: COMPLETED ·Phase: PHASE3

Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients

NCT03374540 ·Status: COMPLETED

Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation

NCT02666157 ·Status: UNKNOWN ·Phase: PHASE4

Study to Gather Information About the Safety of Oral Anticoagulation Drugs and How Well These Drugs Work in Real World for Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem)

NCT04249401 ·Status: COMPLETED

Association Between Genetic Variant Scores and Warfarin Effect

NCT03894878 ·Status: COMPLETED

Prevalence of Post-Thrombotic Syndrome in Deep-Vein Thrombosis (DVT) Patients Treated With Dabigatran

NCT03050138 ·Status: COMPLETED

Cognitive Impairment Related to Atrial Fibrillation Prevention Trial

NCT01994265 ·Status: COMPLETED ·Phase: PHASE4

Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

NCT00448214 ·Status: COMPLETED ·Phase: PHASE2